Filing Details

Accession Number:
0001144204-14-005669
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-03 20:22:23
Reporting Period:
2014-01-30
Filing Date:
2014-02-03
Accepted Time:
2014-02-03 20:22:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1117480 Chimerix Inc CMRX Pharmaceutical Preparations (2834) 330903395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1070009 I Kenneth Moch C/O Chimerix, Inc.
2505 Meridian Parkway, Suite 340
Durham NC 27713
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-30 928 $1.57 6,907 No 4 M Direct
Common Stock Disposition 2014-01-30 928 $20.00 5,979 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-01-30 928 $0.00 928 $1.57
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
224,424 2019-06-19 No 4 M Direct
Footnotes
  1. The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2013.
  2. 64,020 shares became exercisable on June 8, 2009, 1,707 shares became exercisable on August 8, 2010, and the remaining 159,625 shares subject to the option vested and become exercisable in equal monthly installments thereafter.